122 related articles for article (PubMed ID: 8855814)
1. p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan.
Reincke M; Wachenfeld C; Mora P; Thumser A; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3636-8. PubMed ID: 8855814
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies.
Reincke M; Karl M; Travis WH; Mastorakos G; Allolio B; Linehan HM; Chrousos GP
J Clin Endocrinol Metab; 1994 Mar; 78(3):790-4. PubMed ID: 8126158
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors.
Zwermann O; Beuschlein F; Mora P; Weber G; Allolio B; Reincke M
Eur J Endocrinol; 2000 Jun; 142(6):689-95. PubMed ID: 10822234
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas.
Petri BJ; Speel EJ; Korpershoek E; Claessen SM; van Nederveen FH; Giesen V; Dannenberg H; van der Harst E; Dinjens WN; de Krijger RR
Mod Pathol; 2008 Apr; 21(4):407-13. PubMed ID: 18223555
[TBL] [Abstract][Full Text] [Related]
6. p53 protein and its messenger ribonucleic acid in human adrenal tumors.
Adleff V; Rácz K; Tóth M; Varga I; Bezzegh A; Gláz E
J Endocrinol Invest; 1998 Dec; 21(11):753-7. PubMed ID: 9972675
[TBL] [Abstract][Full Text] [Related]
7. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.
Herfarth KK; Wick MR; Marshall HN; Gartner E; Lum S; Moley JF
Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950
[TBL] [Abstract][Full Text] [Related]
8. PCR-SSCP analysis of the p53 gene in tumours of the adrenal gland.
Ballantine DM; Klemm SA; Tunny TJ; Stowasser M; Gordon RD
Clin Exp Pharmacol Physiol; 1996; 23(6-7):582-3. PubMed ID: 8800591
[TBL] [Abstract][Full Text] [Related]
9. The relatively high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas.
Yoshimoto T; Naruse M; Zeng Z; Nishikawa T; Kasajima T; Toma H; Yamamori S; Matsumoto H; Tanabe A; Naruse K; Demura H
J Endocrinol; 1998 Nov; 159(2):247-55. PubMed ID: 9795365
[TBL] [Abstract][Full Text] [Related]
10. Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas.
Moul JW; Bishoff JT; Theune SM; Chang EH
J Urol; 1993 Jun; 149(6):1389-94. PubMed ID: 8501773
[TBL] [Abstract][Full Text] [Related]
11. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations in sporadic adrenocortical tumors.
Ohgaki H; Kleihues P; Heitz PU
Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
[TBL] [Abstract][Full Text] [Related]
13. Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas.
Pilon C; Mulatero P; Barzon L; Veglio F; Garrone C; Boscaro M; Sonino N; Fallo F
J Clin Endocrinol Metab; 1999 Nov; 84(11):4228-31. PubMed ID: 10566677
[TBL] [Abstract][Full Text] [Related]
14. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
Ichijo T; Ueshiba H; Nawata H; Yanase T
Endocr J; 2020 Feb; 67(2):141-152. PubMed ID: 31694993
[TBL] [Abstract][Full Text] [Related]
15. Lack of mutations of exon 2 of the MEN1 gene in endocrine and nonendocrine sporadic tumors.
Costa SC; Nascimento LS; Ferreira FJ; Mattos PS; Camara-Lopes LH; Ward LS
Braz J Med Biol Res; 2001 Jul; 34(7):861-5. PubMed ID: 11449303
[TBL] [Abstract][Full Text] [Related]
16. AKT is highly phosphorylated in pheochromocytomas but not in benign adrenocortical tumors.
Fassnacht M; Weismann D; Ebert S; Adam P; Zink M; Beuschlein F; Hahner S; Allolio B
J Clin Endocrinol Metab; 2005 Jul; 90(7):4366-70. PubMed ID: 15855265
[TBL] [Abstract][Full Text] [Related]
17. P53 gene mutations in pituitary carcinomas.
Tanizaki Y; Jin L; Scheithauer BW; Kovacs K; Roncaroli F; Lloyd RV
Endocr Pathol; 2007; 18(4):217-22. PubMed ID: 18026859
[TBL] [Abstract][Full Text] [Related]
18. Plasma dehydroepiandrosterone sulfate levels in patients with hyperfunctioning and non-hyperfunctioning adrenal tumors before and after adrenal surgery.
Tóth M; Rácz K; Varga I; Adleff V; Jakab C; Fútó L; Kiss R; Gláz E
Eur J Endocrinol; 1997 Mar; 136(3):290-5. PubMed ID: 9100554
[TBL] [Abstract][Full Text] [Related]
19. Discerning malignancy in adrenocortical tumors: are molecular markers useful?
Wachenfeld C; Beuschlein F; Zwermann O; Mora P; Fassnacht M; Allolio B; Reincke M
Eur J Endocrinol; 2001 Sep; 145(3):335-41. PubMed ID: 11517015
[TBL] [Abstract][Full Text] [Related]
20. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
